A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer.

Sixteen patients with metastatic colorectal cancer have been treated with a regimen involving an 120 h continuous infusion of rIL-2, 18 x 10(6) iu m-2 day followed by three injections of 5FU 600 mg m-2 at weekly intervals. Entry criteria included no previous chemotherapy, ambulatory performance stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamblin, T. J., Sadullah, S., Williamson, P., Stevenson, J., Oskam, R., Palmer, P., Franks, C. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968639/
https://www.ncbi.nlm.nih.gov/pubmed/8260371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968639/
https://www.ncbi.nlm.nih.gov/pubmed/8260371

Ejemplares similares